A new US health-economic study, commissioned by Dynavox Group with researchers from Boston College and research firm Augur, examined the impact of high-tech augmentative and alternative communication (AAC) devices on people with cerebral palsy, autism and ALS, as well as their caregivers. Released on 30 June 2026, the study found that AAC use is associated with a 65% improvement in quality of life and a 3.3-times return on investment once healthcare, education and productivity costs are factored in. Seventy-two percent of device users reported feeling better able to express their wishes and preferences after gaining access to AAC technology, and caregivers also reported reduced strain.
Why it matters: Funding bodies and clinicians often need a clear cost-benefit case before approving AAC devices. Independent economic evidence like this can support wider access and faster reimbursement decisions for people who rely on these devices to communicate.
Source: Dynavox Group, via PR Newswire →
Nextrability 